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Multi-matrix, dual polarity, tandem mass spectrometry imaging strategy
applied to a germinated maize seed: toward mass spectrometry imaging of
an untargeted metabolome
Abstract
Mass spectrometry imaging (MSI) provides high spatial resolution information that is unprecedented in
traditional metabolomics analyses; however, the molecular coverage is often limited to a handful of
compounds and is insufficient to understand overall metabolomic changes of a biological system. Here, we
propose an MSI methodology to increase the diversity of chemical compounds that can be imaged and
identified, in order to eventually perform untargeted metabolomic analysis using MSI. In this approach, we
use the desorption/ionization bias of various matrixes for different metabolite classes along with dual
polarities and a tandem MSI strategy. The use of multiple matrixes and dual polarities allows us to visualize
various classes of compounds, while data-dependent MS/MS spectra acquired in the same MSI scans allow us
to identify the compounds directly on the tissue. In a proof of concept application to a germinated corn seed,
a total of 166 unique ions were determined to have high-quality MS/MS spectra, without counting structural
isomers, of which 52 were identified as unique compounds. According to an estimation based on precursor
MSI datasets, we expect over five hundred metabolites could be potentially identified and visualized once all
experimental conditions are optimized and an MS/MS library is available. Lastly, metabolites involved in the
glycolysis pathway and tricarboxylic acid cycle were imaged to demonstrate the potential of this technology to
better understand metabolic biology.
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so	called	‘untargeted	metabolomics’,	are	being	performed	with	traditional	gas	chromatography-electron	ionization-mass	spectrometry	(GC-EI-MS)	or	liquid	chromatography-tandem	mass	spectrometry	(LC-MS/MS)	experiments,	which	require	sample	homogenization,	resulting	in	the	loss	of	spatial	localization	information	of	metabolites.		Untargeted	metabolomic	profiling	is	limited	even	in	traditional	analyses	by	the	difficulty	of	confidently	identifying	metabolites	due	to	the	lack	of	EI-MS	or	MS/MS	databases.	This	issue	is	especially	significant	in	plant	metabolomic	analysis	because	over	200,000	metabolites	are	expected	to	be	present	in	the	plant	kingdom	and	most	of	them	are	unknown.9,	10	For	example,	the	NIST	EI-MS	library	has	over	200,000	entries,	but	most	of	them	are	from	man-made	synthetic	compounds	or	abundant	natural	products.	In	typical	untargeted	GC-MS	profiling	of	a	plant	metabolome,	one-half	to	two-thirds	of	the	metabolites	cannot	be	confidently	identified.11-13	Unknown	compound	identification	in	LC-MS/MS	is	even	more	difficult,	as	its	database	is	much	smaller.		Recently	there	have	been	some	efforts	to	build	widely	applicable	metabolite	MS/MS	databases.	The	Suizdak	group	has	accumulated	MS/MS	spectra	of	12,834	metabolites	(as	of	May	11,	2015)	in	their	Metlin	database	(metlin.scripps.edu),	but	that	number	is	only	about	5%	of	the	number	of	known	metabolites	they	list	(240,588),	not	to	speak	of	unknown	metabolites.	Another	difficulty	arises	from	the	fact	that	MS/MS	spectral	patterns	strongly	depend	on	the	instrument	type	and	collision	energy	used.	Many	of	the	current	MS/MS	databases,	such	as	Metlin,	are	being	constructed	for	a	quadrupole	time-of-flight	mass	spectrometer	(Q-TOF)	and	may	not	be	as	useful	for	other	instruments,	such	as	an	ion	trap.	
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generation	for	both	low	and	high	mass	scans	of	the	Orbitrap	spectra.	The	Peak	Finder	tool	in	MSiReader	was	used	to	select	the	entire	tissue	sample	and	generate	a	peak	list	for	the	masses	found	only	on	tissue.	The	parameters	used	in	the	Peak	Finder	tool	were	a	minimum	of	0.1%	presence	in	the	interrogated	zone	and	a	maximum	presence	of	5%	(or	maximum	S/N	of	two)	in	the	reference	zone.	After	the	peak	list	was	generated,	the	Batch	Processing	feature	of	MSiReader	was	used	to	automatically	generate	images	for	all	the	masses	with	±0.005Da	mass	tolerance	(none	of	these	images	are	used	in	the	text;	rather,	this	served	as	a	quick	and	efficient	way	of	determining	if	peaks	were	localized	on	tissue).	Any	peaks	whose	images	showed	localization	anywhere	off	the	tissue	area	were	removed.	Images	that	were	indeterminate	were	also	generated	in	ImageQuest	to	check	their	localization.	For	masses	that	were	separated	by	less	than	0.02Da,	their	images	were	compared	to	see	if	they	showed	different	localizations.	For	masses	with	the	same	localization,	the	precursor	mass	spectrum	was	carefully	inspected	for	the	image	area	to	determine	if	multiple	masses	were	actually	present.	If	not,	the	mass	of	the	only	peak	in	the	spectrum	for	that	area	was	used.	After	image	filtering,	13C	isotope	peaks	were	manually	removed	from	this	mass	list	in	both	positive	and	negative	modes.	Additionally,	potential	multiple	alkali	metal	adducts	(+Na,	+K)	were	removed	in	positive	mode	data	while	potential	water	loss	peaks	were	removed	in	negative	mode	data.	All	removals	were	based	on	being	within	5ppm	of	the	suspected	mass	values.	This	left	a	final	peak	list	localized	only	on	the	tissue	area	that	are	considered	as	potentially	identifiable	metabolites.	This	mass	list	was	searched	against	the	Metlin	metabolite	database	for	possible	matches	within	5ppm.		 	
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images	are	shown	for	phosphatidylethanolamine	34:2	(PE	34:2),	phosphatidic	acid	36:4	(PA	36:4),	glutamine	(Gln),	malic	acid	(Malic),	uridine	monophosphate	(UMP),	adenosine	diphosphate	(ADP),	uridine	diphosphate	glucose	(UDP-Glc),	phosphonoacetaldehyde	(PALD),	and	two	unknown	compounds	at	m/z	143.035	and	113.024.	M/z	values	used	in	generating	images	are	given	at	the	bottom	of	the	figure.	Red	boxes	highlight	ion	images	more	selectively	detected	with	a	given	matrix	than	in	other	matrixes.	All	ions	are	observed	as	deprotonated	species.	Scale	bars	represent	1mm.			 9AA	is	well	known	for	its	effectiveness	for	small	molecules	in	negative	mode.24,	25	As	shown	in	Figure	2,	it	is	comparable	with	DAN	for	some	organic	acids,	such	as	malic	acid,	but	inefficient	for	some	other	molecules,	such	as	glutamine.23	However,	9AA	shows	much	better	ionization	efficiency	for	nucleotide	type	compounds,	as	has	been	previously	demonstrated.26	Examples	shown	here	include	uridine	monophosphate	(UMP),	adenosine	diphosphate	(ADP),	and	uridine	diphosphate	glucose	(UDP-Glc),	all	distributed	throughout	the	radicle	and	embryo	of	the	seed.	DAN	and	Ag	NPs	show	no	signal	for	this	class	of	compounds	however.	Silver	nanoparticles	were	selected	as	one	of	the	matrixes	in	this	study	because	they	are	known	to	be	effective	for	fatty	acids	and	phospholipids.27,	28	However,	at	least	for	the	current	tissue	sample	of	a	germinated	maize	seed,	they	were	not	as	efficient	for	phospholipids	as	DAN.		Fatty	acids	could	be	successfully	visualized	with	silver	nanoparticles,	but	DAN	produced	much	better	images	(not	shown).		Ag	NPs	showed	better	selectivity	for	some	small	molecules,	such	as	phosphonoacetaldehyde	(PALD),	and	for	two	unidentified	peaks	(likely	small,	organic	acid	type	compounds)	at	m/z	143.035	and	113.024.	PALD	and	m/z	143.035	were	also	detected	with	DAN,	but	with	much	lower	
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signals.	PALD	is	evenly	distributed	throughout	the	embryo	of	the	seed	while	m/z	143.035	and	113.024	species	are	distributed	throughout	the	endosperm	area	of	the	seed.	Similar	results	were	obtained	in	positive	mode	as	demonstrated	with	nine	representative	compounds	in	Figure	3.	DHB,	tungsten	oxide	NPs,	and	iron	oxide	NPs	show	different	desorption	ionization	efficiency	behavior	for	various	classes	of	compounds,	although	there	was	some	similarity	between	the	two	metal	oxide	nanoparticles.	DHB	is	well	known	to	have	good	efficiency	for	a	relatively	wide	variety	of	compounds,	especially	for	large	molecules	including	lipids,	proteins,	and	oligosaccharides.22,	29-31	Neutral	or	cationic	lipids,	such	as	ceramide	42:1	and	phosphatidylcholine	(PC)	34:2,	are	efficiently	detected	with	DHB,	along	with	large	oligosaccharides	and	an	unidentified	compound	at	m/z	972.521.	The	sphingolipid	ceramide	is	very	uniquely	localized	on	the	boundary	area	between	the	embryo	and	endosperm	part	of	the	seed.	PC	34:2	and	the	compound	at	m/z	972.521	are	seen	primarily	in	the	radicle	of	the	seed	with	some	distribution	throughout	the	rest	of	the	embryo.	Large	oligosaccharides,	such	as	heptahexose,	are	localized	in	the	endosperm	area.	Neither	of	the	NPs	shows	any	signal	for	these	classes	of	compounds.	
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MS/MS	spectra	were	available	on	Metlin	or	MassBank,	careful	comparison	was	made	while	considering	the	differences	in	MS/MS	spectral	patterns	between	QTOF	and	ion	trap.	Namely,	our	MS/MS	spectra	were	acquired	in	an	ion	trap,	which	is	known	to	have	a	low	mass	cutoff,	losing	the	fragment	ion	signals	below	28%	of	the	precursor	m/z	values.32	Meanwhile,	QTOF	fragmentation	often	produces	significant	low	mass	fragments	due	to	multiple	fragmentations.	Accordingly,	we	mostly	compared	fragments	in	higher	mass	ranges	and	ignored	the	difference	in	fragment	ion	intensities.	If	MS/MS	spectra	were	not	available	or	did	not	match	with	the	queried	experimental	spectra,	metabolites	matching	the	precursor	mass	either	in	Metlin,	LipidMaps	or	ChemSpider	were	subjected	to	manual	interpretations	to	attempt	to	match	experimental	fragment	spectra	with	expected	fragment	structures.			After	manual	interpretation	of	the	166	MS/MS	spectra,	a	total	of	41	and	25	spectra	were	tentatively	identified	in	positive	and	negative	mode,	respectively,	as	summarized	in	Supplementary	Tables	3	and	4.	Out	of	those,	27	were	determined	to	be	unique	compounds	in	positive	mode	(multiple	cation	adducts	and	identifiable	fragments	such	as	PC	trimethylamine	losses	were	counted	as	the	same	species),	and	all	25	were	unique	in	negative	mode.	These	results	are	summarized	in	Figure	4B	as	Venn	diagrams.		We	were	tentatively	able	to	identify	only	~40%	of	the	ions	in	each	polarity	among	the	potentially	identifiable	MS/MS	spectra,	largely	due	to	the	lack	of	an	MS/MS	database.	MS/MS	spectra	common	in	all	three	matrixes	were	mostly	identified,	with	12	out	of	13	in	positive	mode	and	3	out	of	4	in	negative	mode.	However,	MS/MS	spectra	detected	in	only	one	matrix	had	a	much	lower	success	rate;	e.g.,	only	1	out	12	and	12	out	of	46	identified	in	WO3	and	Fe3O4,	respectively.	This	is	likely	due	to	the	fact	that	the	metabolites	found	in	all	
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three	matrixes	are	present	in	high	abundance,	thus	giving	multiple	sets	of	high-quality	MS/MS	spectra.		In	contrast,	those	found	in	only	one	matrix	might	be	present	in	low	abundance	and/or	with	weak	MS/MS	signals.	In	other	words,	some	high-abundance	compounds	could	be	detected	regardless	of	matrix,	although	ion	signals	could	be	low	in	some	matrixes,	and	thus	have	a	good	chance	to	be	identified.	Hence,	it	is	especially	for	low	abundance	metabolites	that	we	need	to	carefully	optimize	matrix	selectivity	and	MS/MS	conditions	for	effective	detection	and	characterization.		 Figure	5	shows	two	examples	of	metabolites	identified	through	this	analysis.	MS/MS	spectra	for	m/z	833.521	were	obtained	using	both	silver	NPs	and	DAN.	The	two	spectra	are	very	similar	to	each	other,	but	DAN	gives	better	signals	and	is	shown	in	Figure	5A.	Searching	the	precursor	mass	against	the	Metlin	database	gives	19	metabolites	within	5ppm	mass	tolerance,	all	various	structural	isomers	of	PI	(34:2),	but	MS/MS	spectra	are	present	for	none	of	them.	Phospholipids	can	be	manually	characterized	in	MS/MS,	most	notably	from	the	easily	identifiable	loss	of	fatty	acid	side	chains.33,	34	The	most	intense	ion	in	Figure	5A,	m/z	553.3,	corresponds	to	C18:2	fatty	acid	loss	(280.2	Da).	The	C16:0	fatty	acid	loss	(256.2	Da)	is	also	found	at	m/z	577.3.	Further	fragmentation	results	in	the	two	lysophosphatidic	acid	(LPA)	peaks	seen	at	m/z	391.3	and	415.3,	respectively.	These	two	peaks	represent	species	where	the	inositol	headgroup	and	one	of	the	fatty	acid	side	chains	have	fragmented	off.	Additionally,	deprotonated	C16:0	and	C18:2	fatty	acid	fragments	are	found	at	m/z	255.3	and	279.3	respectively.	Thus,	we	can	confidently	assign	this	m/z	833.517	as	PI	(18:2/16:0).		
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if	we	have	an	available,	comprehensive,	automatically	searchable	MS/MS	database.	In	addition	to	database	development,	another	important	step	would	be	to	optimize	experimental	conditions	to	increase	ion	signals	for	low	abundance	compounds	and	also	their	MS/MS	spectral	quality.	While	we	are	working	on	an	MS/MS	database	for	automatic	searching	and	the	optimization	of	experimental	conditions,	in	this	section	we	present	the	analysis	of	precursor	mass	scans	to	extract	how	many	peaks	could	be	assigned	as	potential	metabolites	based	only	on	accurate	mass.	This	allowed	us	to	estimate	how	many	metabolites	could	be	potentially	identified	once	we	have	an	available	database	and	optimized	experimental	conditions.			 The	details	of	how	we	extracted	the	potential	metabolite	mass	list	from	the	precursor	mass	spectra	are	described	in	the	experimental	section.	In	short,	a	peak	list	present	exclusively	on	the	tissue	was	generated	using	the	peak	finder	tool	in	MSiReader	with	at	least	0.1%	ion	abundance	of	the	base	peak;	then,	13C	isotopes,	apparent	multiple	cation	adducts,	and	possible	in-source	fragmentations	of	water	loss	were	manually	removed.	Figure	6A	shows	the	summary	of	this	analysis.	A	total	of	341	and	258	peaks	were	identified	as	potential	unique	metabolites	present	in	the	precursor	mass	spectra	of	positive	and	negative	mode,	respectively.	The	mass	values	were	searched	against	the	Metlin	database	and	Figure	6B	summarizes	the	result	for	those	peaks	that	matched	with	at	least	one	metabolite	in	the	Metlin	database	within	5ppm.	It	suggests	a	total	of	128	and	89	metabolites	could	be	potentially	characterized	in	positive	and	negative	mode,	respectively,	totaling	over	two	hundred	compounds	combining	both	ion	modes	even	in	the	current	‘limited’	metabolome.	Accordingly,	this	analysis	suggests	that	over	two	hundred	compounds	are	potentially	identifiable,	once	an	MS/MS	database	becomes	available	and	
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glyceraldehyde	3-phosphate	(GADP)/dihydroxyacetonephosphate	(DHAP),	1,3	bisphosphoglycerate	(1,3	BPG),	and	phosphoenolpyruvate	(PEP)	are	seen	as	potassium	adducts	and	2-	and	3-phosphoglycerate	(2PG,	3PG)	are	seen	as	potassiated	water	loss	species.			 It	is	clear	from	the	figure	that	the	use	of	various	matrixes	and	both	polarities	is	essential	to	visualize	as	many	compounds	as	possible	in	a	metabolic	pathway.	Overall,	metabolites	involved	in	the	glycolysis	metabolic	pathway	appear	to	be	mostly	enriched	in	the	embryo,	which	is	not	surprising	as	metabolic	biology	is	most	active	when	new	tissues	are	being	generated	such	as	the	radicle	(root)	and	coleoptile	(shoot).	However,	we	could	see	some	localization	differences	between	the	metabolites.	Glucose	looks	to	be	localized	predominantly	to	the	radicle	while	fructose	1,6-bisphosphate	seems	to	be	more	localized	to	the	scutellum	of	the	seed.	Meanwhile,	compounds	like	the	phosphate	sugars	and	phosphoglycerate	compounds	seem	to	be	homogeneously	distributed	throughout	the	entire	embryo	region	of	the	seed.			There	are	several	possible	explanations	why	some	metabolites	show	different	localization	in	the	same	metabolic	pathway.	For	example,	glucose	is	involved	not	only	in	glycolysis	but	also	as	a	building	block	of	many	molecular	components,	which	would	be	especially	needed	in	newly	developing	tissues	such	as	radicles.	Pyruvate	was	not	detected	in	this	study	and	the	images	for	GADP/DHAP	and	1,3BPG	were	also	not	clear,	potentially	due	to	their	low	abundance	and/or	chemical	instability.			 Figure	8	shows	eight	out	of	the	nine	metabolites	in	the	TCA	Cycle,	with	all	of	them	observed	only	in	negative	mode.	This	is	not	surprising	as	all	the	compounds	in	the	pathway	are	organic	acids,	other	than	succinyl-CoA	which	is	the	only	non-observed	species	in	the	
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